Brief: CNS Pharmaceuticals reports Q2 results
15/08/2022 13:07
Aug 15 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* CNS PHARMACEUTICALS INC - NET LOSS FOR THREE MONTHS ENDED
JUNE
30, 2022 WAS ABOUT $3.6 MILLION
Source text for Eikon: ID:nPn9xHdpYa
Further company coverage: CNSP.O
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026